Raymond James Financial’s Columbia Research Enhanced Value ETF REVS Stock Holding History

Raymond James Financial’s Portfolio REVS Stock Details REVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.2M	Buy	579,259 +3,545	+0.6%	+$109K	﹤0.01%	1626
2026 Q1	$16.5M	Buy	575,714 +304,157	+112%	+$8.86M	0.01%	1613
2025 Q4	$7.68M	Buy	271,557 +13,669	+5%	+$386K	﹤0.01%	2178
2025 Q3	$7.21M	Buy	257,888 +57,790	+29%	+$1.57M	﹤0.01%	2187
2025 Q2	$5.26M	Buy	200,098 +159,786	+396%	+$3.96M	﹤0.01%	2348
2025 Q1	$1.02M	Buy	40,312 +1,722	+4%	+$43.8K	﹤0.01%	3478
2024 Q4	$954K	Buy	+38,590	New	+$997K	﹤0.01%	3481

Other funds holding REVS

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

FIB

First Interstate Bank Billings, Montana $1.92B AUM 19.65% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Ruggaard & Associates Hudson, Ohio $279M AUM 18.61% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

Raymond James Financial's REVS Position: Q2 2026 in Review

Raymond James Financial increased its Columbia Research Enhanced Value ETF (REVS) stake by 0.62% in Q2 2026, buying an estimated $109K and bringing the position to 579,259 shares worth $18.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1626.

Raymond James Financial first reported a position in REVS in Q4 2024 and has held it in 7 quarters since. 37 funds tracked by Wall St. Rank hold REVS as of Q2 2026.

Raymond James Financial held 579,259 shares of Columbia Research Enhanced Value ETF worth $18.2M as of Q2 2026.
Raymond James Financial bought 3,545 Columbia Research Enhanced Value ETF shares in Q2 2026, an estimated $109K.
Columbia Research Enhanced Value ETF made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #1626 holding.
Raymond James Financial first reported a position in Columbia Research Enhanced Value ETF in Q4 2024 and has held it in 7 quarters since.
37 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.